Find the right fit for you - faster
Get tailored insights about working at CytomX Therapeutics in one quick step.
Get tailored insights about working at CytomX Therapeutics in one quick step.
Check out your Company Bowl for anonymous work chats.
Veteran hiring commitment
Committed to helping America's military veterans find work
Pay equality pledge
Committed to paying equitably for equal work & experience
Career advancement program
Helping employees "upskill" into higher-paying positions
Diversity commitment
Has programs that support a diverse and inclusive workforce
Olema Oncology is a cancer medicines company dedicated to impacting breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a differentiated oral medicine known as a complete estrogen receptor antagonist (CERAN) initially in development for metastatic breast cancer. Our pipeline also includes OP-3136, a potent, selective oral inhibitor of the KAT6 pathway. At Olema, we are building a focused team committed to our mission with intention and clarity. Working alongside a talented passionate group of leaders and advisors, we strive to create better medicines that aim to help patients feel better, longer. For more information, visit us at www.olema.com.
Employee reviews
